nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—cervical cancer—uterine cancer	0.259	0.763	CtDrD
Topotecan—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.215	0.43	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.148	0.296	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.137	0.274	CiPCiCtD
Topotecan—ovarian cancer—uterine cancer	0.0803	0.236	CtDrD
Topotecan—ABCG2—Dactinomycin—uterine cancer	0.0232	0.214	CbGbCtD
Topotecan—ABCG2—Carboplatin—uterine cancer	0.0156	0.144	CbGbCtD
Topotecan—ABCG2—Etoposide—uterine cancer	0.0131	0.121	CbGbCtD
Topotecan—ABCB1—Progesterone—uterine cancer	0.0106	0.0974	CbGbCtD
Topotecan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00956	0.0881	CbGbCtD
Topotecan—ABCG2—Doxorubicin—uterine cancer	0.00895	0.0825	CbGbCtD
Topotecan—ABCB1—Dactinomycin—uterine cancer	0.00838	0.0772	CbGbCtD
Topotecan—CYP3A4—Progesterone—uterine cancer	0.00633	0.0584	CbGbCtD
Topotecan—ABCB1—Etoposide—uterine cancer	0.00473	0.0436	CbGbCtD
Topotecan—ABCB1—Doxorubicin—uterine cancer	0.00323	0.0297	CbGbCtD
Topotecan—CYP3A4—Etoposide—uterine cancer	0.00283	0.0261	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—uterine cancer	0.00193	0.0178	CbGbCtD
Topotecan—TOP1MT—female reproductive system—uterine cancer	0.000931	0.083	CbGeAlD
Topotecan—TOP1MT—female gonad—uterine cancer	0.000847	0.0756	CbGeAlD
Topotecan—TOP1—myometrium—uterine cancer	0.000843	0.0751	CbGeAlD
Topotecan—TOP1—uterine cervix—uterine cancer	0.000656	0.0585	CbGeAlD
Topotecan—TOP1—smooth muscle tissue—uterine cancer	0.000637	0.0568	CbGeAlD
Topotecan—TOP1—decidua—uterine cancer	0.000625	0.0557	CbGeAlD
Topotecan—TOP1—endometrium—uterine cancer	0.000593	0.0529	CbGeAlD
Topotecan—TOP1—mammalian vulva—uterine cancer	0.000574	0.0512	CbGeAlD
Topotecan—TOP1—uterus—uterine cancer	0.000546	0.0487	CbGeAlD
Topotecan—TOP1MT—lymph node—uterine cancer	0.000545	0.0486	CbGeAlD
Topotecan—TOP1—female gonad—uterine cancer	0.000447	0.0399	CbGeAlD
Topotecan—TOP1—vagina—uterine cancer	0.000444	0.0396	CbGeAlD
Topotecan—ABCG2—myometrium—uterine cancer	0.000299	0.0267	CbGeAlD
Topotecan—TOP1—lymph node—uterine cancer	0.000287	0.0256	CbGeAlD
Topotecan—ABCG2—uterine cervix—uterine cancer	0.000233	0.0207	CbGeAlD
Topotecan—ABCG2—decidua—uterine cancer	0.000222	0.0198	CbGeAlD
Topotecan—ABCG2—endometrium—uterine cancer	0.00021	0.0188	CbGeAlD
Topotecan—ABCG2—mammalian vulva—uterine cancer	0.000204	0.0181	CbGeAlD
Topotecan—ABCG2—uterus—uterine cancer	0.000194	0.0173	CbGeAlD
Topotecan—ABCG2—female gonad—uterine cancer	0.000159	0.0141	CbGeAlD
Topotecan—ABCG2—vagina—uterine cancer	0.000158	0.0141	CbGeAlD
Topotecan—CYP3A4—renal system—uterine cancer	0.000152	0.0135	CbGeAlD
Topotecan—ABCB1—myometrium—uterine cancer	0.000147	0.0131	CbGeAlD
Topotecan—CYP3A4—female reproductive system—uterine cancer	0.000121	0.0108	CbGeAlD
Topotecan—ABCB1—epithelium—uterine cancer	0.000116	0.0103	CbGeAlD
Topotecan—ABCB1—uterine cervix—uterine cancer	0.000115	0.0102	CbGeAlD
Topotecan—ABCB1—decidua—uterine cancer	0.000109	0.00975	CbGeAlD
Topotecan—ABCB1—renal system—uterine cancer	0.000107	0.00957	CbGeAlD
Topotecan—ABCB1—endometrium—uterine cancer	0.000104	0.00925	CbGeAlD
Topotecan—ABCG2—lymph node—uterine cancer	0.000102	0.00909	CbGeAlD
Topotecan—ABCB1—mammalian vulva—uterine cancer	0.0001	0.00895	CbGeAlD
Topotecan—ABCB1—uterus—uterine cancer	9.56e-05	0.00852	CbGeAlD
Topotecan—ABCB1—female reproductive system—uterine cancer	8.59e-05	0.00766	CbGeAlD
Topotecan—Neuropathy peripheral—Etoposide—uterine cancer	7.84e-05	0.00194	CcSEcCtD
Topotecan—ABCB1—female gonad—uterine cancer	7.82e-05	0.00697	CbGeAlD
Topotecan—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	7.8e-05	0.00193	CcSEcCtD
Topotecan—Stomatitis—Etoposide—uterine cancer	7.79e-05	0.00192	CcSEcCtD
Topotecan—Fatigue—Medroxyprogesterone Acetate—uterine cancer	7.79e-05	0.00192	CcSEcCtD
Topotecan—Malaise—Dactinomycin—uterine cancer	7.78e-05	0.00192	CcSEcCtD
Topotecan—ABCB1—vagina—uterine cancer	7.77e-05	0.00693	CbGeAlD
Topotecan—Bone pain—Doxorubicin—uterine cancer	7.74e-05	0.00191	CcSEcCtD
Topotecan—Leukopenia—Dactinomycin—uterine cancer	7.73e-05	0.00191	CcSEcCtD
Topotecan—Constipation—Medroxyprogesterone Acetate—uterine cancer	7.72e-05	0.00191	CcSEcCtD
Topotecan—Colitis—Epirubicin—uterine cancer	7.69e-05	0.0019	CcSEcCtD
Topotecan—Hepatobiliary disease—Etoposide—uterine cancer	7.56e-05	0.00187	CcSEcCtD
Topotecan—Neuropathy—Epirubicin—uterine cancer	7.52e-05	0.00186	CcSEcCtD
Topotecan—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	7.44e-05	0.00184	CcSEcCtD
Topotecan—Pulmonary embolism—Doxorubicin—uterine cancer	7.41e-05	0.00183	CcSEcCtD
Topotecan—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	7.39e-05	0.00182	CcSEcCtD
Topotecan—Myalgia—Dactinomycin—uterine cancer	7.35e-05	0.00181	CcSEcCtD
Topotecan—Hypersensitivity—Progesterone—uterine cancer	7.34e-05	0.00181	CcSEcCtD
Topotecan—Rash maculo-papular—Epirubicin—uterine cancer	7.28e-05	0.0018	CcSEcCtD
Topotecan—Discomfort—Dactinomycin—uterine cancer	7.26e-05	0.00179	CcSEcCtD
Topotecan—Neoplasm—Epirubicin—uterine cancer	7.24e-05	0.00179	CcSEcCtD
Topotecan—Urticaria—Medroxyprogesterone Acetate—uterine cancer	7.17e-05	0.00177	CcSEcCtD
Topotecan—Asthenia—Progesterone—uterine cancer	7.15e-05	0.00177	CcSEcCtD
Topotecan—Hypoaesthesia—Etoposide—uterine cancer	7.14e-05	0.00176	CcSEcCtD
Topotecan—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	7.14e-05	0.00176	CcSEcCtD
Topotecan—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	7.14e-05	0.00176	CcSEcCtD
Topotecan—Colitis—Doxorubicin—uterine cancer	7.12e-05	0.00176	CcSEcCtD
Topotecan—Pruritus—Progesterone—uterine cancer	7.05e-05	0.00174	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	7.01e-05	0.091	CbGpPWpGaD
Topotecan—Infection—Dactinomycin—uterine cancer	7e-05	0.00173	CcSEcCtD
Topotecan—Neuropathy—Doxorubicin—uterine cancer	6.96e-05	0.00172	CcSEcCtD
Topotecan—Sepsis—Epirubicin—uterine cancer	6.95e-05	0.00172	CcSEcCtD
Topotecan—Thrombocytopenia—Dactinomycin—uterine cancer	6.9e-05	0.0017	CcSEcCtD
Topotecan—Diarrhoea—Progesterone—uterine cancer	6.82e-05	0.00168	CcSEcCtD
Topotecan—Rash maculo-papular—Doxorubicin—uterine cancer	6.74e-05	0.00166	CcSEcCtD
Topotecan—Anorexia—Dactinomycin—uterine cancer	6.72e-05	0.00166	CcSEcCtD
Topotecan—Neoplasm—Doxorubicin—uterine cancer	6.7e-05	0.00165	CcSEcCtD
Topotecan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	6.65e-05	0.00164	CcSEcCtD
Topotecan—Dizziness—Progesterone—uterine cancer	6.59e-05	0.00163	CcSEcCtD
Topotecan—Angiopathy—Etoposide—uterine cancer	6.51e-05	0.00161	CcSEcCtD
Topotecan—Immune system disorder—Etoposide—uterine cancer	6.48e-05	0.0016	CcSEcCtD
Topotecan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	6.48e-05	0.0016	CcSEcCtD
Topotecan—Mediastinal disorder—Etoposide—uterine cancer	6.47e-05	0.0016	CcSEcCtD
Topotecan—Chills—Etoposide—uterine cancer	6.44e-05	0.00159	CcSEcCtD
Topotecan—Sepsis—Doxorubicin—uterine cancer	6.43e-05	0.00159	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	6.42e-05	0.00158	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFSF10—uterine cancer	6.39e-05	0.083	CbGpPWpGaD
Topotecan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	6.39e-05	0.00158	CcSEcCtD
Topotecan—Alopecia—Etoposide—uterine cancer	6.34e-05	0.00157	CcSEcCtD
Topotecan—Vomiting—Progesterone—uterine cancer	6.34e-05	0.00156	CcSEcCtD
Topotecan—Rash—Progesterone—uterine cancer	6.28e-05	0.00155	CcSEcCtD
Topotecan—Dermatitis—Progesterone—uterine cancer	6.28e-05	0.00155	CcSEcCtD
Topotecan—Headache—Progesterone—uterine cancer	6.24e-05	0.00154	CcSEcCtD
Topotecan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	6.18e-05	0.00153	CcSEcCtD
Topotecan—Decreased appetite—Dactinomycin—uterine cancer	6.12e-05	0.00151	CcSEcCtD
Topotecan—Dermatitis bullous—Epirubicin—uterine cancer	6.08e-05	0.0015	CcSEcCtD
Topotecan—Fatigue—Dactinomycin—uterine cancer	6.07e-05	0.0015	CcSEcCtD
Topotecan—Back pain—Etoposide—uterine cancer	6.04e-05	0.00149	CcSEcCtD
Topotecan—Pain—Dactinomycin—uterine cancer	6.02e-05	0.00149	CcSEcCtD
Topotecan—Anaphylactoid reaction—Epirubicin—uterine cancer	6.01e-05	0.00148	CcSEcCtD
Topotecan—Muscle spasms—Etoposide—uterine cancer	6.01e-05	0.00148	CcSEcCtD
Topotecan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	5.97e-05	0.00147	CcSEcCtD
Topotecan—Lethargy—Epirubicin—uterine cancer	5.93e-05	0.00147	CcSEcCtD
Topotecan—Nausea—Progesterone—uterine cancer	5.92e-05	0.00146	CcSEcCtD
Topotecan—Feeling abnormal—Dactinomycin—uterine cancer	5.81e-05	0.00143	CcSEcCtD
Topotecan—Ill-defined disorder—Etoposide—uterine cancer	5.8e-05	0.00143	CcSEcCtD
Topotecan—Anaemia—Etoposide—uterine cancer	5.77e-05	0.00143	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—uterine cancer	5.76e-05	0.00142	CcSEcCtD
Topotecan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	5.74e-05	0.00142	CcSEcCtD
Topotecan—Rash—Medroxyprogesterone Acetate—uterine cancer	5.69e-05	0.00141	CcSEcCtD
Topotecan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	5.69e-05	0.0014	CcSEcCtD
Topotecan—Headache—Medroxyprogesterone Acetate—uterine cancer	5.66e-05	0.0014	CcSEcCtD
Topotecan—Malaise—Etoposide—uterine cancer	5.63e-05	0.00139	CcSEcCtD
Topotecan—Dermatitis bullous—Doxorubicin—uterine cancer	5.63e-05	0.00139	CcSEcCtD
Topotecan—Leukopenia—Etoposide—uterine cancer	5.59e-05	0.00138	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—uterine cancer	5.57e-05	0.00138	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—uterine cancer	5.57e-05	0.00138	CcSEcCtD
Topotecan—Anaphylactoid reaction—Doxorubicin—uterine cancer	5.56e-05	0.00137	CcSEcCtD
Topotecan—Cardiac arrest—Epirubicin—uterine cancer	5.53e-05	0.00137	CcSEcCtD
Topotecan—Lethargy—Doxorubicin—uterine cancer	5.49e-05	0.00136	CcSEcCtD
Topotecan—Cough—Etoposide—uterine cancer	5.45e-05	0.00135	CcSEcCtD
Topotecan—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.36e-05	0.00132	CcSEcCtD
Topotecan—Chest pain—Etoposide—uterine cancer	5.32e-05	0.00131	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	5.28e-05	0.0013	CcSEcCtD
Topotecan—Discomfort—Etoposide—uterine cancer	5.25e-05	0.0013	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Epirubicin—uterine cancer	5.24e-05	0.00129	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—uterine cancer	5.19e-05	0.00128	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Epirubicin—uterine cancer	5.13e-05	0.00127	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—uterine cancer	5.12e-05	0.00126	CcSEcCtD
Topotecan—Anaphylactic shock—Etoposide—uterine cancer	5.1e-05	0.00126	CcSEcCtD
Topotecan—Infection—Etoposide—uterine cancer	5.07e-05	0.00125	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—uterine cancer	5.05e-05	0.00125	CcSEcCtD
Topotecan—ABCB1—lymph node—uterine cancer	5.03e-05	0.00448	CbGeAlD
Topotecan—Thrombocytopenia—Etoposide—uterine cancer	4.99e-05	0.00123	CcSEcCtD
Topotecan—Skin disorder—Etoposide—uterine cancer	4.95e-05	0.00122	CcSEcCtD
Topotecan—Hyperhidrosis—Etoposide—uterine cancer	4.93e-05	0.00122	CcSEcCtD
Topotecan—Anorexia—Etoposide—uterine cancer	4.86e-05	0.0012	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	4.85e-05	0.0012	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—uterine cancer	4.82e-05	0.00119	CcSEcCtD
Topotecan—Pancytopenia—Epirubicin—uterine cancer	4.77e-05	0.00118	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—uterine cancer	4.75e-05	0.00117	CcSEcCtD
Topotecan—Neutropenia—Epirubicin—uterine cancer	4.7e-05	0.00116	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—STAR—uterine cancer	4.61e-05	0.0599	CbGpPWpGaD
Topotecan—Paraesthesia—Etoposide—uterine cancer	4.58e-05	0.00113	CcSEcCtD
Topotecan—Weight increased—Epirubicin—uterine cancer	4.57e-05	0.00113	CcSEcCtD
Topotecan—Dyspnoea—Etoposide—uterine cancer	4.55e-05	0.00112	CcSEcCtD
Topotecan—Pneumonia—Epirubicin—uterine cancer	4.51e-05	0.00111	CcSEcCtD
Topotecan—Infestation NOS—Epirubicin—uterine cancer	4.48e-05	0.00111	CcSEcCtD
Topotecan—Infestation—Epirubicin—uterine cancer	4.48e-05	0.00111	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—uterine cancer	4.48e-05	0.00111	CcSEcCtD
Topotecan—Rash—Dactinomycin—uterine cancer	4.44e-05	0.0011	CcSEcCtD
Topotecan—Decreased appetite—Etoposide—uterine cancer	4.43e-05	0.00109	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—uterine cancer	4.42e-05	0.00109	CcSEcCtD
Topotecan—Gastrointestinal disorder—Etoposide—uterine cancer	4.4e-05	0.00109	CcSEcCtD
Topotecan—Fatigue—Etoposide—uterine cancer	4.4e-05	0.00109	CcSEcCtD
Topotecan—Neuropathy peripheral—Epirubicin—uterine cancer	4.39e-05	0.00108	CcSEcCtD
Topotecan—Stomatitis—Epirubicin—uterine cancer	4.37e-05	0.00108	CcSEcCtD
Topotecan—Pain—Etoposide—uterine cancer	4.36e-05	0.00108	CcSEcCtD
Topotecan—Constipation—Etoposide—uterine cancer	4.36e-05	0.00108	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—uterine cancer	4.35e-05	0.00107	CcSEcCtD
Topotecan—Sweating—Epirubicin—uterine cancer	4.3e-05	0.00106	CcSEcCtD
Topotecan—Hepatobiliary disease—Epirubicin—uterine cancer	4.24e-05	0.00105	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—uterine cancer	4.23e-05	0.00105	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—uterine cancer	4.23e-05	0.00104	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—uterine cancer	4.2e-05	0.00104	CcSEcCtD
Topotecan—Nausea—Dactinomycin—uterine cancer	4.18e-05	0.00103	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—uterine cancer	4.17e-05	0.00103	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—uterine cancer	4.17e-05	0.00103	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—uterine cancer	4.15e-05	0.00102	CcSEcCtD
Topotecan—Infestation—Doxorubicin—uterine cancer	4.15e-05	0.00102	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—uterine cancer	4.06e-05	0.001	CcSEcCtD
Topotecan—Urticaria—Etoposide—uterine cancer	4.05e-05	0.001	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—uterine cancer	4.04e-05	0.000998	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—uterine cancer	4.04e-05	0.000998	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—uterine cancer	4.03e-05	0.000996	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—uterine cancer	4.03e-05	0.000995	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—uterine cancer	4.03e-05	0.000995	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—uterine cancer	4.02e-05	0.000993	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—uterine cancer	4e-05	0.000988	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—uterine cancer	3.99e-05	0.000986	CcSEcCtD
Topotecan—Sweating—Doxorubicin—uterine cancer	3.98e-05	0.000982	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—uterine cancer	3.92e-05	0.000968	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	3.92e-05	0.0508	CbGpPWpGaD
Topotecan—Epistaxis—Doxorubicin—uterine cancer	3.91e-05	0.000966	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—HNF1B—uterine cancer	3.76e-05	0.0488	CbGpPWpGaD
Topotecan—Hypersensitivity—Etoposide—uterine cancer	3.76e-05	0.000928	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—uterine cancer	3.74e-05	0.000924	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—uterine cancer	3.73e-05	0.000921	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—uterine cancer	3.72e-05	0.000919	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—uterine cancer	3.7e-05	0.000915	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—uterine cancer	3.69e-05	0.000912	CcSEcCtD
Topotecan—Asthenia—Etoposide—uterine cancer	3.66e-05	0.000903	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—uterine cancer	3.65e-05	0.000901	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—uterine cancer	3.63e-05	0.000897	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—uterine cancer	3.63e-05	0.000895	CcSEcCtD
Topotecan—Chills—Epirubicin—uterine cancer	3.61e-05	0.000891	CcSEcCtD
Topotecan—Pruritus—Etoposide—uterine cancer	3.61e-05	0.000891	CcSEcCtD
Topotecan—Alopecia—Epirubicin—uterine cancer	3.55e-05	0.000878	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—uterine cancer	3.5e-05	0.000865	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—uterine cancer	3.49e-05	0.000861	CcSEcCtD
Topotecan—Back pain—Epirubicin—uterine cancer	3.39e-05	0.000836	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—uterine cancer	3.38e-05	0.000834	CcSEcCtD
Topotecan—Dizziness—Etoposide—uterine cancer	3.37e-05	0.000833	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—uterine cancer	3.37e-05	0.000831	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—uterine cancer	3.36e-05	0.00083	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—uterine cancer	3.35e-05	0.000828	CcSEcCtD
Topotecan—Chills—Doxorubicin—uterine cancer	3.34e-05	0.000825	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—uterine cancer	3.29e-05	0.000812	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—uterine cancer	3.25e-05	0.000802	CcSEcCtD
Topotecan—Vomiting—Etoposide—uterine cancer	3.24e-05	0.0008	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—uterine cancer	3.24e-05	0.0008	CcSEcCtD
Topotecan—Anaemia—Epirubicin—uterine cancer	3.24e-05	0.000799	CcSEcCtD
Topotecan—Rash—Etoposide—uterine cancer	3.21e-05	0.000794	CcSEcCtD
Topotecan—Dermatitis—Etoposide—uterine cancer	3.21e-05	0.000793	CcSEcCtD
Topotecan—Headache—Etoposide—uterine cancer	3.19e-05	0.000789	CcSEcCtD
Topotecan—Malaise—Epirubicin—uterine cancer	3.16e-05	0.00078	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—uterine cancer	3.13e-05	0.000774	CcSEcCtD
Topotecan—Back pain—Doxorubicin—uterine cancer	3.13e-05	0.000774	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—uterine cancer	3.12e-05	0.000769	CcSEcCtD
Topotecan—Cough—Epirubicin—uterine cancer	3.06e-05	0.000755	CcSEcCtD
Topotecan—Nausea—Etoposide—uterine cancer	3.03e-05	0.000748	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—uterine cancer	3.01e-05	0.000742	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—uterine cancer	2.99e-05	0.00074	CcSEcCtD
Topotecan—Chest pain—Epirubicin—uterine cancer	2.98e-05	0.000736	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—uterine cancer	2.98e-05	0.000736	CcSEcCtD
Topotecan—Myalgia—Epirubicin—uterine cancer	2.98e-05	0.000736	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.96e-05	0.000731	CcSEcCtD
Topotecan—Discomfort—Epirubicin—uterine cancer	2.95e-05	0.000727	CcSEcCtD
Topotecan—Malaise—Doxorubicin—uterine cancer	2.92e-05	0.000722	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—uterine cancer	2.9e-05	0.000716	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—uterine cancer	2.86e-05	0.000706	CcSEcCtD
Topotecan—Infection—Epirubicin—uterine cancer	2.84e-05	0.000701	CcSEcCtD
Topotecan—Cough—Doxorubicin—uterine cancer	2.83e-05	0.000698	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—uterine cancer	2.8e-05	0.000692	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—uterine cancer	2.8e-05	0.000691	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—uterine cancer	2.78e-05	0.000686	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—uterine cancer	2.76e-05	0.000682	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—uterine cancer	2.76e-05	0.000681	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—uterine cancer	2.76e-05	0.000681	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—uterine cancer	2.76e-05	0.000681	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.74e-05	0.000676	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—uterine cancer	2.73e-05	0.000673	CcSEcCtD
Topotecan—Anorexia—Epirubicin—uterine cancer	2.72e-05	0.000673	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—uterine cancer	2.64e-05	0.000653	CcSEcCtD
Topotecan—Infection—Doxorubicin—uterine cancer	2.63e-05	0.000649	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.6e-05	0.000643	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—uterine cancer	2.59e-05	0.00064	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—uterine cancer	2.59e-05	0.000639	CcSEcCtD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	2.58e-05	0.0334	CbGpPWpGaD
Topotecan—Skin disorder—Doxorubicin—uterine cancer	2.57e-05	0.000634	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—uterine cancer	2.57e-05	0.000634	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—uterine cancer	2.56e-05	0.000631	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—uterine cancer	2.55e-05	0.000629	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—uterine cancer	2.52e-05	0.000622	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—uterine cancer	2.52e-05	0.000621	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.51e-05	0.0326	CbGpPWpGaD
Topotecan—Decreased appetite—Epirubicin—uterine cancer	2.48e-05	0.000613	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—uterine cancer	2.47e-05	0.000609	CcSEcCtD
Topotecan—Fatigue—Epirubicin—uterine cancer	2.46e-05	0.000608	CcSEcCtD
Topotecan—Pain—Epirubicin—uterine cancer	2.44e-05	0.000604	CcSEcCtD
Topotecan—Constipation—Epirubicin—uterine cancer	2.44e-05	0.000604	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—RRM2—uterine cancer	2.44e-05	0.0316	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—EZH2—uterine cancer	2.41e-05	0.0313	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.41e-05	0.000595	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—uterine cancer	2.37e-05	0.000586	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—uterine cancer	2.36e-05	0.000582	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—uterine cancer	2.36e-05	0.000582	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—uterine cancer	2.34e-05	0.000577	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.33e-05	0.0302	CbGpPWpGaD
Topotecan—Dyspepsia—Doxorubicin—uterine cancer	2.33e-05	0.000575	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—uterine cancer	2.3e-05	0.000568	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.28e-05	0.000564	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—uterine cancer	2.28e-05	0.000563	CcSEcCtD
Topotecan—Urticaria—Epirubicin—uterine cancer	2.27e-05	0.000561	CcSEcCtD
Topotecan—Constipation—Doxorubicin—uterine cancer	2.26e-05	0.000558	CcSEcCtD
Topotecan—Pain—Doxorubicin—uterine cancer	2.26e-05	0.000558	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—uterine cancer	2.26e-05	0.000558	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—uterine cancer	2.26e-05	0.000558	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—uterine cancer	2.18e-05	0.000538	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—uterine cancer	2.16e-05	0.000534	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.12e-05	0.0275	CbGpPWpGaD
Topotecan—Hypersensitivity—Epirubicin—uterine cancer	2.11e-05	0.00052	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—uterine cancer	2.1e-05	0.000519	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—uterine cancer	2.09e-05	0.000516	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—uterine cancer	2.09e-05	0.000516	CcSEcCtD
Topotecan—Asthenia—Epirubicin—uterine cancer	2.05e-05	0.000506	CcSEcCtD
Topotecan—Pruritus—Epirubicin—uterine cancer	2.02e-05	0.000499	CcSEcCtD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	1.98e-05	0.0257	CbGpPWpGaD
Topotecan—Diarrhoea—Epirubicin—uterine cancer	1.96e-05	0.000483	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—uterine cancer	1.95e-05	0.000481	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—uterine cancer	1.9e-05	0.000469	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.9e-05	0.0246	CbGpPWpGaD
Topotecan—Dizziness—Epirubicin—uterine cancer	1.89e-05	0.000467	CcSEcCtD
Topotecan—ABCB1—ABC-family proteins mediated transport—ABCC9—uterine cancer	1.88e-05	0.0244	CbGpPWpGaD
Topotecan—Pruritus—Doxorubicin—uterine cancer	1.87e-05	0.000462	CcSEcCtD
Topotecan—Vomiting—Epirubicin—uterine cancer	1.82e-05	0.000449	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—uterine cancer	1.81e-05	0.000447	CcSEcCtD
Topotecan—Rash—Epirubicin—uterine cancer	1.8e-05	0.000445	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—uterine cancer	1.8e-05	0.000445	CcSEcCtD
Topotecan—Headache—Epirubicin—uterine cancer	1.79e-05	0.000442	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—uterine cancer	1.75e-05	0.000432	CcSEcCtD
Topotecan—Nausea—Epirubicin—uterine cancer	1.7e-05	0.000419	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—uterine cancer	1.68e-05	0.000415	CcSEcCtD
Topotecan—Rash—Doxorubicin—uterine cancer	1.67e-05	0.000412	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—uterine cancer	1.67e-05	0.000411	CcSEcCtD
Topotecan—Headache—Doxorubicin—uterine cancer	1.66e-05	0.000409	CcSEcCtD
Topotecan—Nausea—Doxorubicin—uterine cancer	1.57e-05	0.000388	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.41e-05	0.0183	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—uterine cancer	1.34e-05	0.0174	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—uterine cancer	1.23e-05	0.016	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.04e-05	0.0135	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.61e-06	0.0125	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.07e-06	0.0118	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	8.84e-06	0.0115	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PTEN—uterine cancer	8.49e-06	0.011	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.43e-06	0.0109	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—EP300—uterine cancer	8.1e-06	0.0105	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	7.99e-06	0.0104	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	7.71e-06	0.01	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	7.21e-06	0.00936	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.79e-06	0.00881	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—EP300—uterine cancer	6.38e-06	0.00828	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.24e-06	0.0081	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	6.05e-06	0.00785	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.04e-06	0.00783	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—uterine cancer	5.79e-06	0.00752	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	5.43e-06	0.00704	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.1e-06	0.00662	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	4.68e-06	0.00607	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	4.6e-06	0.00597	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	4.54e-06	0.00589	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.19e-06	0.00544	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	4.17e-06	0.00541	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	4.03e-06	0.00523	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.76e-06	0.00487	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.73e-06	0.00484	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.63e-06	0.00471	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.56e-06	0.00462	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	3.51e-06	0.00456	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.39e-06	0.00439	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.34e-06	0.00434	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.27e-06	0.00424	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	2.93e-06	0.00381	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.74e-06	0.00356	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.59e-06	0.00336	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.4e-06	0.00311	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.4e-06	0.00311	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SRD5A2—uterine cancer	2.35e-06	0.00305	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NDUFB11—uterine cancer	2.35e-06	0.00305	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.27e-06	0.00295	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.18e-06	0.00282	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.11e-06	0.00273	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.05e-06	0.00266	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.03e-06	0.00263	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.98e-06	0.00257	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.96e-06	0.00255	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.95e-06	0.00254	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.95e-06	0.00253	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.92e-06	0.0025	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.85e-06	0.0024	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1B1—uterine cancer	1.7e-06	0.00221	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STAR—uterine cancer	1.7e-06	0.00221	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.67e-06	0.00216	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.46e-06	0.00189	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.45e-06	0.00189	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.44e-06	0.00187	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POLD1—uterine cancer	1.33e-06	0.00173	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SRD5A2—uterine cancer	1.27e-06	0.00165	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NDUFB11—uterine cancer	1.27e-06	0.00165	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1C1—uterine cancer	1.25e-06	0.00162	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.23e-06	0.00159	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—RRM2—uterine cancer	1.11e-06	0.00144	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DCN—uterine cancer	1.08e-06	0.0014	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.07e-06	0.00138	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP11A1—uterine cancer	1.02e-06	0.00132	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.88e-07	0.00128	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1C3—uterine cancer	9.61e-07	0.00125	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.33e-07	0.00121	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1B1—uterine cancer	9.19e-07	0.00119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STAR—uterine cancer	9.19e-07	0.00119	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.1e-07	0.00118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.68e-07	0.00113	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.22e-07	0.00107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.83e-07	0.00102	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.83e-07	0.00102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STK11—uterine cancer	7.49e-07	0.000972	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP19A1—uterine cancer	7.49e-07	0.000972	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POLD1—uterine cancer	7.21e-07	0.000936	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.99e-07	0.000907	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1C1—uterine cancer	6.75e-07	0.000876	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.42e-07	0.000833	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.21e-07	0.000806	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RRM2—uterine cancer	6.01e-07	0.000781	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DCN—uterine cancer	5.84e-07	0.000758	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.66e-07	0.000735	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STAR—uterine cancer	5.66e-07	0.000735	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—uterine cancer	5.63e-07	0.00073	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP11A1—uterine cancer	5.5e-07	0.000714	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.24e-07	0.00068	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1C3—uterine cancer	5.2e-07	0.000674	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POLD1—uterine cancer	4.44e-07	0.000577	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.16e-07	0.00054	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STK11—uterine cancer	4.05e-07	0.000525	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP19A1—uterine cancer	4.05e-07	0.000525	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RRM2—uterine cancer	3.71e-07	0.000481	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DCN—uterine cancer	3.6e-07	0.000467	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.39e-07	0.00044	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.2e-07	0.000415	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—uterine cancer	3.13e-07	0.000406	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—uterine cancer	3.04e-07	0.000395	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EP300—uterine cancer	2.98e-07	0.000387	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.49e-07	0.000324	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STK11—uterine cancer	2.49e-07	0.000324	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—uterine cancer	2.21e-07	0.000287	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—uterine cancer	1.87e-07	0.000243	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—uterine cancer	1.8e-07	0.000234	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—uterine cancer	1.69e-07	0.00022	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EP300—uterine cancer	1.61e-07	0.000209	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—uterine cancer	1.19e-07	0.000155	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—uterine cancer	1.04e-07	0.000135	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EP300—uterine cancer	9.94e-08	0.000129	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—uterine cancer	9.75e-08	0.000127	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.35e-08	9.54e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—uterine cancer	6.01e-08	7.8e-05	CbGpPWpGaD
